НовостиBenzingaGuggenheim Initiates Coverage On Yarrow Bioscience with Buy Rating, Announces Price Target of $60 Guggenheim Initiates Coverage On Yarrow Bioscience with Buy Rating, Announces Price Target of $60 Benzinga 2026.11.06 15:55 (GMT+0) Открыть на Benzinga Другие новости